Clinical Trial Update: Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of K-312 in healthy subjects has completed, with hyperlipidemia liste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• K-312

Snippet

Sponsor: Kowa Research Institute, Inc. | Conditions: Hyperlipidemia | Phase 1 | Status: COMPLETED